Schroder Investment Management Group Eye Point Pharmaceuticals, Inc. Transaction History
Schroder Investment Management Group
- $83.3 Billion
- Q1 2024
A detailed history of Schroder Investment Management Group transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 306,206 shares of EYPT stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
306,206
Previous 180,000
70.11%
Holding current value
$2.66 Million
Previous $4.16 Million
52.18%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
176Shares Held
53.9MCall Options Held
764KPut Options Held
1.57M-
Cormorant Asset Management, LP Boston, MA6.89MShares$60 Million8.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.76MShares$41.4 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.76MShares$32.7 Million3.33% of portfolio
-
Franklin Resources Inc San Mateo, CA3.39MShares$29.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$24.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $296M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...